Loading clinical trials...
Loading clinical trials...
Chemotherapy drugs, used in the treatment of cancer, have the potential of inducing peripheral neuropathy (PN) as a side effect. This side effect is commonly referred to as CIPN, or chemotherapy-induc...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Luminate Medical, Inc.
NCT06614322 · Painful Peripheral Neuropathy, Diabetic Peripheral Neuropathic Pain (DPN), and more
NCT06807294 · Chemotherapy Induced Peripheral Neuropathy (CIPN), Peripheral Neuropathy Due to Chemotherapy, and more
NCT06962579 · Chemotherapy Induced Peripheral Neuropathy (CIPN)
NCT06799351 · Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia, and more
NCT07319481 · Chemotherapy Induced Peripheral Neuropathy (CIPN)
Palomar Health (Topography)
Poway, California
Eastern Connecticut Hematology Oncology
Norwich, Connecticut
Hialeah Hospital
Hialeah, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions